Donald A. Wuchterl
CIK: 0001857854
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ABEO
ABEONA THERAPEUTICS INC.
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Feb 2, 2026ABEO
ABEONA THERAPEUTICS INC.
Sale(S)Direct14.8K shares at avg. $5.09$75K - Jan 26, 2026ABEO
ABEONA THERAPEUTICS INC.
Award(A)Direct37.3K shares- - Jul 8, 2025ABEO
ABEONA THERAPEUTICS INC.
Sale(S)Direct5.2K shares at avg. $5.82$30K - Jan 31, 2025ABEO
ABEONA THERAPEUTICS INC.
Award(A)Direct36.1K shares-
1-4 of 4 transactions
About Wuchterl Donald A.
Wuchterl Donald A. (SEC CIK 0001857854) files insider reports with the SEC as Director of ABEONA THERAPEUTICS INC. (ABEO).
Signal8 holds 4 ownership filings by Wuchterl Donald A., all Form 4s, filed between Feb 3, 2025 and Feb 2, 2026. Those filings report 4 transactions, from Jan 31, 2025 to Feb 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Wuchterl Donald A.'s filings is in CLEVELAND, OH.
Recent filings by Wuchterl Donald A.
Other insiders filing for ABEONA THERAPEUTICS INC. (ABEO)
- Seshadri Vishwas, Chief Executive Officer
- Vazzano Joseph Walter, Chief Financial Officer
- O'Malley Brendan M., SVP, Chief Legal Officer
- Vasanthavada Madhav, Chief Commercial Officer
- Alvino Mark, Director
- Alland Leila, Director